substance p has been researched along with Diffuse Myofascial Pain Syndrome in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (14.63) | 18.7374 |
1990's | 11 (26.83) | 18.2507 |
2000's | 15 (36.59) | 29.6817 |
2010's | 8 (19.51) | 24.3611 |
2020's | 1 (2.44) | 2.80 |
Authors | Studies |
---|---|
Chang, CT; Chang, KV; Chen, CC; Chu, YC; Han, DS; Lee, CH; Li, MH; Lin, SH; Shieh, YD; Wang, JL | 1 |
Akcay, F; Karatay, S; Okur, SC; Uzkeser, H; Yildirim, K | 1 |
Björkegren, K; Burell, G; Karlsson, B; Kristiansson, P; Nyberg, F; Svärdsudd, K | 1 |
Chen, CC; Han, DS; Lee, CH; Shieh, YD | 1 |
Freitag, K; Freitag, MSC; Izquierdo, MDC; Pipis, H; Theoharides, TC; Tsilioni, I | 1 |
Andersen, ML; Araujo, P; Frange, C; Hachul, H; Hirotsu, C; Tufik, S | 1 |
Gleason, RM; Russell, IJ; Stewart, JM; Theoharides, TC; Tsilioni, I | 1 |
da Costa, ED; Paiva, ES; Scheinberg, M | 1 |
Brezinschek, HP | 1 |
Arshad, M; Arshad, N; Iqbal, R; Mughal, MS | 1 |
Cohen, M; Lyon, P; Quintner, J | 1 |
Russell, IJ | 3 |
Fiebich, B; Haus, U; Müller, W; Stratz, T | 1 |
Akyol, O; Ozgocmen, S; Ozyurt, H; Sogut, S | 1 |
Jonas, C | 1 |
Cheng, TO | 1 |
Eichling, PS; Sahni, J | 1 |
Peterson, EL | 1 |
Gendreau, JF; Kranzler, JD; Rao, SG | 1 |
Spaeth, M; Staud, R | 1 |
Felder, M | 1 |
Bennett, RM | 2 |
Houvenagel, E | 1 |
Alboukrek, D; Littman, B; Lopez, Y; MacKillip, F; Michalek, JE; Orr, MD; Russell, IJ; Vipraio, GA | 1 |
Franke, S; Hein, G; Kluge, H; Sprott, H | 1 |
Alarcón, GS; Bradley, LA; Gay, RE; Gay, S; Mussell, HG; Oh, SJ; Sprott, H; Tseng, A; Wintersberger, W | 1 |
Eneroth, P; Evengard, B; Fredrikson, S; Henriksson, KG; Lindh, G; Lindquist, L; Nilsson, CG; Terenius, L | 1 |
Pierau, FK; Sann, H | 1 |
Ackenheil, M; Bondy, B; Müller-Bardorff, H; Pongratz, DE; Schwarz, MJ; Späth, M | 1 |
Alarcón, GS; Bradley, LA | 1 |
Rau, CL; Russell, IJ | 1 |
Bragee, B; Liu, Z; Nyberg, F; Welin, M | 1 |
Biasi, G; De Stefano, R; Franceschini, E; Frati, E; Manganelli, S; Marcolongo, R; Selvi, E; Villanova, M | 1 |
Kopp, S | 1 |
Førre, Ø; Helle, R; Kåss, E; Terenius, L; Vaerøy, H | 1 |
Chiu, B; Inman, RD; Reynolds, WJ | 1 |
Førre, O; Helle, R; Kåss, E; Terenius, L; Vaeroy, H | 1 |
Førre, O; Kåss, E; Sakurada, T; Terenius, L; Vaerøy, H | 1 |
19 review(s) available for substance p and Diffuse Myofascial Pain Syndrome
Article | Year |
---|---|
Fibromyalgia and sleep in animal models: a current overview and future directions.
Topics: Animals; Chronic Pain; Disease Models, Animal; Evidence-Based Medicine; Fatigue; Fibromyalgia; Humans; Pain Threshold; Rats; Serotonin; Severity of Illness Index; Sleep; Sleep Wake Disorders; Substance P | 2014 |
Fibromyalgia: an update and immunological aspects.
Topics: Antibodies; Autoantibodies; Chronic Disease; Evoked Potentials, Somatosensory; Fibromyalgia; Headache; Humans; Interleukin-2; Neural Pathways; Nociceptors; Pain Threshold; Polymers; Posterior Horn Cells; Psychophysiologic Disorders; Substance P | 2008 |
[Mechanisms of muscle pain : significance of trigger points and tender points].
Topics: Connective Tissue; Diagnosis, Differential; Fibromyalgia; Humans; Inflammation Mediators; Muscle, Skeletal; Myofascial Pain Syndromes; Pain, Referred; Palpation; Substance P | 2008 |
Pathophysiology and antioxidant status of patients with fibromyalgia.
Topics: Animals; Antioxidants; Fatigue Syndrome, Chronic; Fibromyalgia; Humans; Hypothalamo-Hypophyseal System; Mice; Oxidative Stress; Pain; Pituitary-Adrenal System; Reactive Nitrogen Species; Reactive Oxygen Species; Substance P | 2011 |
An evolutionary stress-response hypothesis for chronic widespread pain (fibromyalgia syndrome).
Topics: Animals; Biological Evolution; Central Nervous System Sensitization; Chronic Pain; Fibromyalgia; Humans; Nociception; Receptors, Neurokinin-1; Stress, Psychological; Substance P | 2011 |
The promise of substance P inhibitors in fibromyalgia.
Topics: Benzene Derivatives; Fibromyalgia; Humans; Neurokinin-1 Receptor Antagonists; Receptors, Neurokinin-1; Substance P | 2002 |
Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide.
Topics: Antioxidants; Autonomic Nervous System; Cerebrovascular Circulation; Cytokines; Diet; Fatigue Syndrome, Chronic; Fibromyalgia; Genetic Predisposition to Disease; Humans; Hypothalamo-Hypophyseal System; Muscles; Nitric Oxide; Oxidative Stress; Pituitary-Adrenal System; Regional Blood Flow; Substance P | 2006 |
Menopause related sleep disorders.
Topics: Depression; Estrogen Replacement Therapy; Estrogens; Female; Fibromyalgia; Humans; Hydrocortisone; Melatonin; Menopause; Phytotherapy; Polysomnography; Progesterone; Serotonin; Sleep Apnea Syndromes; Sleep Initiation and Maintenance Disorders; Sleep Stages; Substance P; Testosterone | 2005 |
Fibromyalgia--management of a misunderstood disorder.
Topics: Anticonvulsants; Antidepressive Agents; Causality; Chronic Disease; Diagnosis, Differential; Exercise; Fibromyalgia; Humans; Hypothalamo-Hypophyseal System; Medical History Taking; Neuromuscular Agents; Nurse Practitioners; Nurse's Role; Nursing Assessment; Patient Care Planning; Patient Education as Topic; Physical Examination; Pituitary-Adrenal System; Primary Health Care; Serotonin; Social Support; Substance P; United States | 2007 |
Understanding the fibromyalgia syndrome.
Topics: Animals; Chronic Pain; Fibromyalgia; Humans; Hypothalamo-Hypophyseal System; Neuroimaging; Pituitary-Adrenal System; Serotonin; Substance P; Syndrome | 2007 |
Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia.
Topics: Afferent Pathways; Brain; Fibromyalgia; Humans; Hyperalgesia; Hypothalamo-Hypophyseal System; Nerve Fibers, Unmyelinated; Nerve Growth Factor; Neuronal Plasticity; Neurotransmitter Agents; Pain Threshold; Peripheral Nerves; Pituitary-Adrenal System; Recruitment, Neurophysiological; Serotonin; Substance P | 2008 |
[The fibrositis syndrome (author's transl)].
Topics: Adult; Behavior Therapy; Chlorpromazine; Edema; Endorphins; Female; Fibromyalgia; Humans; Male; Middle Aged; Neurotic Disorders; Obesity; Pain; Pain Management; Sleep Wake Disorders; Substance P; Syndrome; Tryptophan | 1980 |
[Fibromyalgia: pathogenic concepts].
Topics: Enkephalins; Fibromyalgia; Humans; Hypothyroidism; Mental Disorders; Neurotransmitter Agents; Pain Measurement; Serotonin; Sleep Wake Disorders; Substance P | 1993 |
Fibromyalgia and the facts. Sense or nonsense.
Topics: Affect; Fibromyalgia; Humans; Muscles; Neurosecretory Systems; Nociceptors; Pain Threshold; Physical Exertion; Stress, Physiological; Substance P | 1993 |
Advances in fibromyalgia: possible role for central neurochemicals.
Topics: Analgesia; Animals; Calcitonin Gene-Related Peptide; Dynorphins; Fibromyalgia; Humans; Hyperalgesia; Neurotransmitter Agents; Serotonin; Substance P | 1998 |
Efferent functions of C-fiber nociceptors.
Topics: Animals; Calcitonin Gene-Related Peptide; Capsaicin; Efferent Pathways; Fibromyalgia; Humans; Inflammation; Nerve Fibers; Neurokinin A; Nociceptors; Skin; Substance P; Swine | 1998 |
Neurochemical pathogenesis of fibromyalgia.
Topics: Animals; Fibromyalgia; Humans; Neurotransmitter Agents; Nociceptors; Pain Threshold; Serotonin; Substance P | 1998 |
Is fibromyalgia a distinct clinical syndrome?
Topics: Autonomic Nervous System; Chronic Disease; Demography; Fibromyalgia; Humans; Neurologic Examination; Neurosecretory Systems; Nociceptors; Pain; Pain Threshold; Spinal Cord; Substance P | 2000 |
Neuroendocrine, immune, and local responses related to temporomandibular disorders.
Topics: Arthritis; Calcitonin Gene-Related Peptide; Dinoprostone; Facial Pain; Fibromyalgia; Humans; Hyperalgesia; Inflammation Mediators; Interleukin-1; Leukotriene B4; Masseter Muscle; Neuroimmunomodulation; Neuropeptide Y; Neuropeptides; Neurosecretory Systems; Open Bite; Serotonin; Substance P; Synovial Fluid; Temporomandibular Joint Disorders; Tumor Necrosis Factor-alpha | 2001 |
3 trial(s) available for substance p and Diffuse Myofascial Pain Syndrome
Article | Year |
---|---|
Effects of Acupuncture Treatment on Fibromyalgia Symptoms, Serotonin, and Substance P Levels: A Randomized Sham and Placebo-Controlled Clinical Trial.
Topics: Acupuncture Therapy; Adult; Female; Fibromyalgia; Humans; Middle Aged; Pain Management; Pain Measurement; Serotonin; Substance P; Treatment Outcome; Young Adult | 2018 |
Decline of substance P levels after stress management with cognitive behaviour therapy in women with the fibromyalgia syndrome.
Topics: Cognitive Behavioral Therapy; Female; Fibromyalgia; Humans; Middle Aged; Pain; Psychometrics; Substance P; Surveys and Questionnaires | 2019 |
Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome.
Topics: Adult; Female; Fibromyalgia; Humans; Male; Middle Aged; Predictive Value of Tests; Radioimmunoassay; Regression Analysis; Spinal Puncture; Substance P | 1994 |
19 other study(ies) available for substance p and Diffuse Myofascial Pain Syndrome
Article | Year |
---|---|
A role for substance P and acid-sensing ion channel 1a in prolotherapy with dextrose-mediated analgesia in a mouse model of chronic muscle pain.
Topics: Acid Sensing Ion Channels; Analgesia; Animals; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Fibromyalgia; Glucose; Hyperalgesia; Mice; Myalgia; Prolotherapy; Substance P | 2022 |
Involvement of Substance P in the Analgesic Effect of Low-Level Laser Therapy in a Mouse Model of Chronic Widespread Muscle Pain.
Topics: Acids; Animals; Capsaicin; Chronic Pain; Cnidarian Venoms; Disease Models, Animal; Dose-Response Relationship, Drug; Fibromyalgia; Laser Therapy; Low-Level Light Therapy; Mice; Mice, Inbred C57BL; Mice, Knockout; Musculoskeletal Pain; Protein Precursors; Signal Transduction; Substance P; Tachykinins; TRPV Cation Channels | 2019 |
Effects of an Extract of Salmon Milt on Symptoms and Serum TNF and Substance P in Patients With Fibromyalgia Syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Dietary Supplements; Fatigue; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Salmon; Semen; Substance P; Tumor Necrosis Factor-alpha; Young Adult | 2019 |
Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.
Topics: Adult; Aged; Biomarkers; Corticotropin-Releasing Hormone; Cytokines; Female; Fibromyalgia; Humans; Inflammation Mediators; Interleukin-6; Male; Mast Cells; Middle Aged; Substance P; Tachykinins; Tumor Necrosis Factor-alpha | 2016 |
Influence of tropisetron on the serum substance P levels in fibromyalgia patients.
Topics: Female; Fibromyalgia; Humans; Indoles; Middle Aged; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Substance P; Time Factors; Tropisetron | 2004 |
[Fibromyalgia: rheumatologic or psychiatric disease?].
Topics: Adult; Anxiety Disorders; Child; Diagnosis, Differential; Fibromyalgia; Genetic Predisposition to Disease; Humans; Mental Disorders; Prevalence; Risk Factors; Somatoform Disorders; Stress Disorders, Post-Traumatic; Substance P | 2006 |
Acupuncture treatment for musculoskeletal chest pain.
Topics: Acupuncture Therapy; Chest Pain; Fibromyalgia; Humans; Keratan Sulfate; Osteoarthritis; Serotonin; Substance P | 2007 |
Fibrositis: misnomer for a common rheumatic disorder.
Topics: Diagnosis, Differential; Enkephalins; Fatigue; Fibromyalgia; Humans; Rheumatic Diseases; Substance P; Terminology as Topic | 1981 |
Pain treatment of fibromyalgia by acupuncture.
Topics: Acupuncture Therapy; Biomarkers; Blood Platelets; Chronic Disease; Female; Fibromyalgia; Humans; Male; Middle Aged; Pain; Pain Management; Pain Measurement; Platelet Count; Serotonin; Substance P; Treatment Outcome | 1998 |
Immunohistochemical and molecular studies of serotonin, substance P, galanin, pituitary adenylyl cyclase-activating polypeptide, and secretoneurin in fibromyalgic muscle tissue.
Topics: Adult; Aged; DNA Primers; Female; Fibromyalgia; Galanin; Humans; Immunoenzyme Techniques; Male; Middle Aged; Muscle, Skeletal; Neuropeptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Polymerase Chain Reaction; RNA, Messenger; Secretogranin II; Serotonin; Substance P | 1998 |
Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome.
Topics: Adult; Aged; Aged, 80 and over; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Humans; Male; Reference Values; Substance P | 1998 |
Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients.
Topics: Adult; Biomarkers; Female; Fibromyalgia; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Pain; Sleep; Substance P; Tryptophan | 1999 |
Is Chiari malformation associated with increased levels of substance P and clinical symptoms in persons with fibromyalgia?
Topics: Arnold-Chiari Malformation; Fibromyalgia; Humans; Substance P | 1999 |
A high-recovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid.
Topics: Fibromyalgia; Humans; Opioid Peptides; Radioimmunoassay; Reproducibility of Results; Sensitivity and Specificity; Substance P | 2000 |
Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome.
Topics: Adult; Analysis of Variance; Female; Fibromyalgia; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Middle Aged; Muscle, Skeletal; Myofascial Pain Syndromes; Neurons, Afferent; Substance P | 2000 |
Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.
Topics: Adult; Female; Fibromyalgia; Humans; Raynaud Disease; Smoking; Substance P | 1988 |
Plasma substance P levels in fibrositis.
Topics: Adult; Female; Fibromyalgia; Humans; Male; Middle Aged; Radioimmunoassay; Substance P | 1988 |
Cerebrospinal fluid levels of beta-endorphin in patients with fibromyalgia (fibrositis syndrome).
Topics: Adult; beta-Endorphin; Female; Fibromyalgia; Humans; Middle Aged; Radioimmunoassay; Substance P | 1988 |
Modulation of pain in fibromyalgia (fibrositis syndrome): cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP).
Topics: Calcitonin Gene-Related Peptide; Female; Fibromyalgia; Humans; Neuropeptides; Pain; Palliative Care; Peptide Fragments; Radioimmunoassay; Substance P | 1989 |